Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Decreased pulmonary exacerbations and lower intravenous antibiotic usage following vanzacaftor/tezacaftor/deutivacaftor treatment in people with cystic fibrosis with F508del-minimal function genotypes.
Journal: The European respiratory journal
Published: November 25, 2025
Domain-Specific Olfaction in Children and Adults in the Era of Modulator Therapy for Cystic Fibrosis.
Journal: Pediatric pulmonology
Published: March 29, 2025
Psychometric validity of the 22-item sinonasal outcome test in cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: February 03, 2025
Vanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials.
Journal: The Lancet. Respiratory medicine
Published: October 25, 2024
Implementation of an outpatient clinical pharmacy service at an adult cystic fibrosis center.
Journal: Journal of the American Pharmacists Association : JAPhA
Published: July 05, 2024
Unusual presentation of ROS1 rearranged metastatic non-small cell lung cancer.
Journal: Respiratory medicine case reports
Published: May 08, 2024
Determining the minimal clinically important difference for the questionnaire of olfactory disorders in people with cystic fibrosis and factors associated with improvement after highly effective modulator therapy.
Journal: International forum of allergy & rhinology
Published: August 27, 2023
Olfaction, body mass index, and quality of life with cystic fibrosis combination therapy.
Journal: International forum of allergy & rhinology
Published: March 12, 2023
Safety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.
Journal: The Lancet. Respiratory medicine
Published: September 29, 2022
The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 05, 2022
Body mass index and additional risk factors for cancer in adults with cystic fibrosis.
Journal: Cancer causes & control : CCC
Published: November 18, 2021
Last Updated: 09/26/2026